Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force
Open Access
- 20 December 2022
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 128, 121-127
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Active smoking and COVID-19: a double-edged swordEuropean Journal of Internal Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical determinants for fatality of 44,672 patients with COVID-19Critical Care, 2020
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysisPLOS ONE, 2019
- MERS transmission and risk factors: a systematic reviewBMC Public Health, 2018
- Cigarette Smoking and InfectionArchives of internal medicine (1960), 2004
- Not 15 But 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden StudiesRespiratory Medicine, 2003
- Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2000